Vasopressin therapy in Parkinson's disease
- PMID: 7211172
- DOI: 10.1111/j.1600-0404.1980.tb03024.x
Vasopressin therapy in Parkinson's disease
Abstract
A double-blind crossover pilot study was carried out in six patients with Parkinson's disease in order to test the possible therapeutic effect of L-vasopressin after treatment for 1 month with 30 I.U. intranasally daily. The investigation was completed in five cases. No effects was noticed after LVP treatment.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources